BioXcel Therapeutics (BTAI) Times Interest Earned (2022 - 2025)
Historic Times Interest Earned for BioXcel Therapeutics (BTAI) over the last 4 years, with Q3 2025 value amounting to -$3.25.
- BioXcel Therapeutics' Times Interest Earned rose 1936.74% to -$3.25 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.05, marking a year-over-year increase of 4217.97%. This contributed to the annual value of -$4.44 for FY2024, which is 6555.07% up from last year.
- BioXcel Therapeutics' Times Interest Earned amounted to -$3.25 in Q3 2025, which was up 1936.74% from -$3.75 recorded in Q2 2025.
- BioXcel Therapeutics' Times Interest Earned's 5-year high stood at -$2.53 during Q1 2025, with a 5-year trough of -$4497.1 in Q1 2022.
- Over the past 4 years, BioXcel Therapeutics' median Times Interest Earned value was -$6.7 (recorded in 2024), while the average stood at -$308.54.
- Within the past 5 years, the most significant YoY rise in BioXcel Therapeutics' Times Interest Earned was 9966.19% (2023), while the steepest drop was 4093.48% (2023).
- Quarter analysis of 4 years shows BioXcel Therapeutics' Times Interest Earned stood at -$18.11 in 2022, then skyrocketed by 68.06% to -$5.79 in 2023, then soared by 55.02% to -$2.6 in 2024, then dropped by 25.02% to -$3.25 in 2025.
- Its last three reported values are -$3.25 in Q3 2025, -$3.75 for Q2 2025, and -$2.53 during Q1 2025.